Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT II.

[1]  J. Leipsic,et al.  Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[2]  Andrew S. Mugglin,et al.  Transcatheter Aortic‐Valve Replacement with a Self‐Expanding Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[3]  J. Bavaria,et al.  Cognition and Cerebral Infarction in Older Adults After Surgical Aortic Valve Replacement. , 2019, The Annals of thoracic surgery.

[4]  J. Tijssen,et al.  Predictors, Incidence, and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation Complicated by Stroke: From the CENTER-Collaboration , 2019, Circulation. Cardiovascular interventions.

[5]  Jeffrey N. Browndyke,et al.  Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative , 2018, European heart journal.

[6]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[7]  Eugene Blackstone,et al.  Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to Outcomes: The STS/ACC TVT Registry. , 2017, Journal of the American College of Cardiology.

[8]  L. Fleisher,et al.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[9]  Andrew S. Mugglin,et al.  Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients , 2017, The New England journal of medicine.

[10]  R. Virmani,et al.  Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement. , 2017, Journal of the American College of Cardiology.

[11]  V. Rajagopal,et al.  Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report From the CoreValve Trials , 2016, Circulation. Cardiovascular interventions.

[12]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[13]  A. Brickman,et al.  A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. , 2015, European heart journal.

[14]  B. Iung,et al.  Cerebrovascular events post-transcatheter aortic valve replacement in a large cohort of patients: a FRANCE-2 registry substudy. , 2014, JACC. Cardiovascular interventions.

[15]  Maurice Buchbinder,et al.  Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.

[16]  A. Brickman,et al.  Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[17]  J. Bavaria,et al.  Put Into Perspective for the Practicing Clinician 2243 Stroke After Aortic Valve Surgery : Results From a Prospective Cohort , 2014 .

[18]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.

[19]  Raimund Erbel,et al.  Cerebral Embolization During Transcatheter Aortic Valve Implantation: A Transcranial Doppler Study , 2012, Circulation.

[20]  A. Schmermund,et al.  Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[21]  P. Wenaweser,et al.  Transcranial Doppler-detected cerebral embolic load during transcatheter aortic valve implantation. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[22]  M. Mack,et al.  ACQUIRED CARDIOVASCULAR DISEASE Transcatheter ( TAVR ) versus surgical ( AVR ) aortic valve replacement : Occurrence , hazard , risk factors , and consequences of neurologic events in the PARTNER trial , 2012 .

[23]  S. Pocock,et al.  The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities , 2011, European heart journal.

[24]  S. Plein,et al.  Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status , 2011, Heart.

[25]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[26]  S. Achenbach,et al.  Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. , 2010, JACC. Cardiovascular interventions.

[27]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[28]  H. Jäger,et al.  New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS) , 2010, Lancet Neurology.

[29]  M. Forsting,et al.  Silent and Apparent Cerebral Ischemia After Percutaneous Transfemoral Aortic Valve Implantation: A Diffusion-Weighted Magnetic Resonance Imaging Study , 2010, Circulation.

[30]  D. Schoenfeld,et al.  Combining mortality and longitudinal measures in clinical trials. , 1999, Statistics in medicine.